NCT00438256 Neoadjuvant Accelerated Short Course Radiation Therapy With Proton Beam and Capecitabine for Resectable Pancreatic Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT00436072 ZD6474, Cetuximab, and Irinotecan in Patients With Metastatic Colorectal Cancer Status COMPLETED Phase PHASE1
NCT00431210 Epstein-Barr Virus-Specific Immunotherapy for Nasopharyngeal Carcinoma Status COMPLETED Phase PHASE1
NCT00429910 Natural History Study of Patients With Chronic Myelogenous Leukemia Status COMPLETED Phase N/A
NCT00428233 Banking of Chronic Lymphocytic Leukemia Tumor Cells for Vaccine Generation Status COMPLETED Phase PHASE1
NCT00426205 GM-CSF Vaccinations After Allogeneic Blood Stem Cell Transplantation in Patients With Advanced Myeloid Malignancies Status COMPLETED Phase NA
NCT00424515 Imatinib in Patients With Mucosal or Acral/Lentiginous Melanoma Status COMPLETED Phase PHASE2
NCT00422799 Combination Bortezomib and Rituximab in Patients With Waldenstrom's Macroglobulinemia (WM) Status COMPLETED Phase PHASE2
NCT00422656 Perifosine in Patients With Relapsed/Refractory Waldenstrom's Macroglobulinemia Status COMPLETED Phase PHASE2
NCT00418093 Oxaliplatin, Gemcitabine and Bevacizumab in Women With Recurrent Mullerian Carcinoma Status TERMINATED Phase PHASE2
NCT00409292 RAD001 in Previously Treated Patients With Metastatic Pancreatic Cancer Status COMPLETED Phase PHASE2
NCT00402545 C-TPF in Patients With Newly Diagnosed Locally Advanced Squamous Cell Carcinoma of the Head and Neck Status COMPLETED Phase PHASE1
NCT00400946 05-001: Treatment of Acute Lymphoblastic Leukemia in Children Status COMPLETED Phase PHASE3
NCT00398710 A Phase II Study of Perifosine in Patients With Relapsed/Refractory Waldenström's Macroglobulinemia Status COMPLETED Phase PHASE2
NCT00394433 Docetaxel, Cisplatin, Irinotecan and Bevacizumab (TPCA) in Metastatic Esophageal and Gastric Cancer Status COMPLETED Phase PHASE2
NCT00392665 Bevacizumab/Tarceva and Tarceva/Sulindac in Squamous Cell Carcinoma of the Head and Neck Status TERMINATED Phase PHASE2
NCT00385853 PTK787/ZK 222584 in Combination With Temozolomide and Radiation in Patients With Glioblastoma Taking Enzyme-Inducing Anti-Epileptic Drugs Status COMPLETED Phase PHASE1